Globus Medical Sees FY24 Adj. EPS $2.80-$2.90 Vs $2.82 Est.; Revenue $2.47B-$2.49B Vs $2.475B Est.
Portfolio Pulse from Benzinga Newsdesk
Globus Medical has provided its financial guidance for FY24, projecting adjusted EPS between $2.80 and $2.90, compared to the estimated $2.82. The company also expects revenue to be in the range of $2.47 billion to $2.49 billion, against the estimated $2.475 billion.

August 06, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical has provided its financial guidance for FY24, projecting adjusted EPS between $2.80 and $2.90, compared to the estimated $2.82. The company also expects revenue to be in the range of $2.47 billion to $2.49 billion, against the estimated $2.475 billion.
The financial guidance provided by Globus Medical is slightly above the market estimates for both EPS and revenue. This positive outlook is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100